Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Carbimazole 5mg Tablets - UK EMC Drug Approval Details

Approvals/UK EMC/Carbimazole 5mg Tablets

Approved

STANDARD

Carbimazole 5mg Tablets

Glenmark Pharmaceuticals Europe Ltd🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 64ba1b0bf47baa72
Company: Glenmark Pharmaceuticals Europe Ltd
Type: Standard

Approval Details

Approval Id: 64ba1b0bf47baa72
Drug Approval Emc Name: Carbimazole 5mg Tablets
Drug Name: Carbimazole 5mg Tablets
Company Name: Glenmark Pharmaceuticals Europe Ltd
Company Address: Building 2, Croxley Park, Watford, WD18 8YA
Company Website: //www.glenmarkpharma.com
Company Telephone: +44 (0)1923 202 950
Company Medical Info Direct Line: 0800 458 0383
Company Stock Availability: +44 (0)1923 202 950
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

64ba1b0bf47baa72

Type

Standard

Back to UK EMC Approvals